SCHEMBL24699019

SCHEMBL24699019

Cc1ccc2ccc(C)c(N(c3cccnc3)c3ccc4ccc5c(N(c6cccnc6)c6c(C)ccc7ccc(C)cc67)ccc6ccc3c4c65)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
GAA P10253 1/20 0.35
GFER P55789 1/20 0.34
MAP2K4 P45985 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP17A1 P05093 1/20 0.33
LMNA P02545 1/20 0.32
ALDH1A1 P00352 4/20 0.32
KMT2A Q03164 3/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 4/20 0.31
TSHR P16473 2/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
RAB9A P51151 3/20 0.31
MAOA P21397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21473769 0.85 CYP1A2 (0.38) KDM4EGAACYP1A2CYP2A6LMNA
SCHEMBL2267716 0.79 CYP1A2 (0.36) KDM4EGAACYP1A2CYP2A6CYP17A1
SCHEMBL21475592 0.79 CYP1A2 (0.35) KDM4EGAACYP1A2CYP2A6LMNA
SCHEMBL24699292 0.79 CYP1A2 (0.38) KDM4EGAACYP1A2CYP2A6LMNA
SCHEMBL21475593 0.78 CYP1A2 (0.34) KDM4EGAACYP1A2CYP2A6LMNA
SCHEMBL13304243 0.76 KCNA5 (0.40) KDM4EGAACYP1A2CYP17A1ALDH1A1
SCHEMBL24699018 0.75 CYP2A6 (0.35) KDM4EGAACYP1A2CYP2A6LMNA
SCHEMBL24699291 0.74 CYP1A2 (0.35) KDM4EGAACYP1A2CYP2A6LMNA
SCHEMBL21473901 0.73 MAOA (0.33) KDM4ECYP1A2CYP2A6LMNAALDH1A1
SCHEMBL21475591 0.73 LMNA (0.32) LMNAALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512039-B2 Aromatic amine derivatives, preparation methods therefor, and uses thereof GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2022-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11512039-B2 Aromatic amine derivatives, preparation methods therefor, and uses thereof SLC7A1, WEE1, SLC7A5 KDM4E 1103/4885GAA 1321/4885GFER 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.